Valuation : Scholar Rock Holding Corporation

Market Cap 680.66Cr 587.14Cr 552.29Cr 503.15Cr 946.16Cr 65TCr 951.29Cr 6.53TCr 2.54TCr 33TCr 2.56TCr 2.5TCr 1,09000Cr P/E 2026 *
-17.2x
P/E 2027 * -21.7x
Enterprise Value 648.94Cr 559.78Cr 526.56Cr 479.7Cr 902.08Cr 62TCr 906.96Cr 6.22TCr 2.42TCr 31TCr 2.44TCr 2.38TCr 1,03900Cr EV / Sales 2026 *
1,142x
EV / Sales 2027 * 43.8x
Free-Float
99.23%
Yield 2026 *
-
Yield 2027 * -
1 day-1.60%
1 week-4.05%
Current month-1.60%
1 month+18.17%
3 months+17.94%
6 months+26.25%
Current year+26.88%
1 week 55.33
Extreme 55.33
60.18
1 month 45.73
Extreme 45.73
61.76
Current year 38.75
Extreme 38.75
61.76
1 year 27.07
Extreme 27.07
61.76
3 years 5.94
Extreme 5.94
61.76
5 years 4.32
Extreme 4.325
61.76
10 years 4.32
Extreme 4.325
70
Manager TitleAgeSince
Chief Executive Officer 59 27/04/2025
Director of Finance/CFO 62 27/04/2025
Chief Operating Officer 58 27/04/2025
Director TitleAgeSince
Chairman 59 01/07/2017
Director/Board Member 53 01/08/2014
Director/Board Member 78 01/10/2016
Date Insider Type Main position Quantity % Market Cap. Importance
01/07/26 Sell

Director

-2,544 0.0022%
01/07/26 Sell

Director

-5,446 0.0047%
01/07/26 Sell

Director

-3,053 0.0027%
Change 5-day change 1-year change 3-year change Capi.($)
-1.60%-4.05%+71.18%+788.55% 680.66Cr
-0.25%-4.10%+38.38%+92.61% 6.82TCr
+1.21%+0.80%+46.29%+85.32% 6.42TCr
-0.25%-1.92%-10.72%+436.70% 2.65TCr
+0.33%-10.61%+1.95%-16.27% 2.56TCr
+1.18%-2.23%+30.87%-19.04% 1.99TCr
-6.09%-12.08%+226.11%+375.00% 1.71TCr
+0.24%-5.67%-1.52%+532.32% 1.49TCr
+4.12%+0.30%+52.03%+150.18% 1.41TCr
-0.24%+5.18%+23.04%+190.97% 1.24TCr
Average -0.13%-3.45%+47.76%+261.64% 2.7TCr
Weighted average by Cap. +0.11%-2.90%+41.96%+173.49%

Financials

2026 *2027 *
Net sales 56.84L 49.03L 46.12L 42.02L 79.01L 54Cr 79.44L 5.45Cr 2.12Cr 27Cr 2.13Cr 2.09Cr 91Cr 15Cr 13Cr 12Cr 11Cr 20Cr 1.39TCr 20Cr 140.18Cr 55Cr 705.5Cr 55Cr 54Cr 2.34TCr
Net income -43Cr -37Cr -35Cr -31Cr -59Cr -4.04TCr -59Cr -408.01Cr -158.81Cr -2.05TCr -159.7Cr -156.23Cr -6.81TCr -36Cr -31Cr -30Cr -27Cr -51Cr -3.45TCr -51Cr -349Cr -135.84Cr -1.76TCr -136.6Cr -133.64Cr -5.82TCr
Net Debt -32Cr -27Cr -26Cr -23Cr -44Cr -3.01TCr -44Cr -304.23Cr -118.41Cr -1.53TCr -119.08Cr -116.49Cr -5.08TCr -40Cr -35Cr -33Cr -30Cr -56Cr -3.84TCr -57Cr -388.39Cr -151.17Cr -1.95TCr -152.02Cr -148.72Cr -6.48TCr
Logo Scholar Rock Holding Corporation
Scholar Rock Holding Corporation is a biopharmaceutical company. The Company focuses on improving the lives of children and adults with spinal muscular atrophy (SMA) and additional rare, severe and debilitating neuromuscular diseases. Its pipeline product candidates include apitegromab, a subcutaneous formulation of apitegromab, and SRK-439. The Apitegromab is an investigational fully human, intravenously administered monoclonal antibody designed to inhibit myostatin activation by selectively binding the pro- and latent forms of myostatin in the skeletal muscle. The SRK-439, is an investigational, subcutaneously administered fully human anti-pro/latent myostatin antibody that has high inhibitory potency while maintaining selectivity towards myostatin. Its early-stage pipeline includes additional programs for the treatment of patients with rare, severe, and debilitating neuromuscular diseases.
Employees
289
Date Price Change Volume
01/26/01 $55.89 -1.60% 7,63,186
31/26/31 $56.80 -1.73% 9,87,264
28/26/28 $57.80 -2.46% 8,09,724
27/26/27 $59.26 -1.30% 6,20,744
26/26/26 $60.04 +3.07% 22,81,289
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
55.89USD
Average target price
60.75USD
Spread / Average Target
+8.70%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SRRK Stock